217 related articles for article (PubMed ID: 12655057)
1. Evidence against the presence of an anandamide transporter.
Glaser ST; Abumrad NA; Fatade F; Kaczocha M; Studholme KM; Deutsch DG
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4269-74. PubMed ID: 12655057
[TBL] [Abstract][Full Text] [Related]
2. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
Kaczocha M; Hermann A; Glaser ST; Bojesen IN; Deutsch DG
J Biol Chem; 2006 Apr; 281(14):9066-75. PubMed ID: 16461355
[TBL] [Abstract][Full Text] [Related]
3. Anandamide transport inhibition by the vanilloid agonist olvanil.
Beltramo M; Piomelli D
Eur J Pharmacol; 1999 Jan; 364(1):75-8. PubMed ID: 9920187
[TBL] [Abstract][Full Text] [Related]
4. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase.
Deutsch DG; Glaser ST; Howell JM; Kunz JS; Puffenbarger RA; Hillard CJ; Abumrad N
J Biol Chem; 2001 Mar; 276(10):6967-73. PubMed ID: 11118429
[TBL] [Abstract][Full Text] [Related]
5. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
[TBL] [Abstract][Full Text] [Related]
6. Further evidence for the existence of a specific process for the membrane transport of anandamide.
Ligresti A; Morera E; Van Der Stelt M; Monory K; Lutz B; Ortar G; Di Marzo V
Biochem J; 2004 May; 380(Pt 1):265-72. PubMed ID: 14969584
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.
Ruiz-Llorente L; Ortega-Gutiérrez S; Viso A; Sánchez MG; Sánchez AM; Fernández C; Ramos JA; Hillard C; Lasunción MA; López-Rodríguez ML; Díaz-Laviada I
Br J Pharmacol; 2004 Feb; 141(3):457-67. PubMed ID: 14718261
[TBL] [Abstract][Full Text] [Related]
8. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
9. Anandamide transport: a critical review.
Glaser ST; Kaczocha M; Deutsch DG
Life Sci; 2005 Aug; 77(14):1584-604. PubMed ID: 15979096
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
11. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.
Day TA; Rakhshan F; Deutsch DG; Barker EL
Mol Pharmacol; 2001 Jun; 59(6):1369-75. PubMed ID: 11353795
[TBL] [Abstract][Full Text] [Related]
12. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.
De Petrocellis L; Bisogno T; Maccarrone M; Davis JB; Finazzi-Agro A; Di Marzo V
J Biol Chem; 2001 Apr; 276(16):12856-63. PubMed ID: 11278420
[TBL] [Abstract][Full Text] [Related]
13. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
16. Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter?
Fasia L; Karava V; Siafaka-Kapadai A
Eur J Biochem; 2003 Sep; 270(17):3498-506. PubMed ID: 12919314
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants for recognition and translocation by the anandamide transporter.
Piomelli D; Beltramo M; Glasnapp S; Lin SY; Goutopoulos A; Xie XQ; Makriyannis A
Proc Natl Acad Sci U S A; 1999 May; 96(10):5802-7. PubMed ID: 10318965
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
19. Anandamide hydrolysis by human cells in culture and brain.
Maccarrone M; van der Stelt M; Rossi A; Veldink GA; Vliegenthart JF; Agrò AF
J Biol Chem; 1998 Nov; 273(48):32332-9. PubMed ID: 9822713
[TBL] [Abstract][Full Text] [Related]
20. Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin.
Sandberg A; Fowler CJ
Chem Phys Lipids; 2005 Apr; 134(2):131-9. PubMed ID: 15784231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
